More than two dozen state attorneys general are urging federal authorities to fine several large drug makers for curtailing the discounts they offer through a federal program for safety-net hospitals.
The state officials are concerned about the viability of the 340B drug discount program, which requires drug makers to offer discounts estimated to be 25% to 50% — but which can be much higher — on all outpatient drugs to hospitals and clinics serving low-income populations. There are about 12,700 so-called covered entities, including hospitals, in the program.
About the Author Reprints
